299 related articles for article (PubMed ID: 20686085)
21. Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan.
Nadkarni AS; Schliep T; Khan L; Zeana CB
Am J Infect Control; 2009 Mar; 37(2):121-6. PubMed ID: 19249638
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.
Gaibani P; Lombardo D; Lewis RE; Mercuri M; Bonora S; Landini MP; Ambretti S
J Antimicrob Chemother; 2014 Jul; 69(7):1856-65. PubMed ID: 24648503
[TBL] [Abstract][Full Text] [Related]
23. Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill/in vivo Galleria mellonella survival model analysis.
Borjan J; Meyer KA; Shields RK; Wenzler E
Int J Antimicrob Agents; 2020 Jan; 55(1):105852. PubMed ID: 31770627
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of polymyxin B plus imipenem, meropenem, or tigecycline against KPC-2-producing Enterobacteriaceae with high MICs for these antimicrobials.
Barth N; Ribeiro VB; Zavascki AP
Antimicrob Agents Chemother; 2015; 59(6):3596-7. PubMed ID: 25801560
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of Klebsiella pneumoniae carbapenemase - and New Delhi metallo-beta-lactamase-positive K. pneumoniae in Sergipe, Brazil, and combination therapy as a potential treatment option.
Vivas R; Dolabella SS; Barbosa AAT; Jain S
Rev Soc Bras Med Trop; 2020; 53():e20200064. PubMed ID: 32401864
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Cha R
Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of in vitro methods for testing tigecycline combinations against carbapenemase-producing Klebsiella pneumoniae isolates.
Papoutsaki V; Galani I; Papadimitriou E; Karantani I; Karaiskos I; Giamarellou H
J Glob Antimicrob Resist; 2020 Mar; 20():98-104. PubMed ID: 31398495
[TBL] [Abstract][Full Text] [Related]
28. Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom.
Woodford N; Zhang J; Warner M; Kaufmann ME; Matos J; Macdonald A; Brudney D; Sompolinsky D; Navon-Venezia S; Livermore DM
J Antimicrob Chemother; 2008 Dec; 62(6):1261-4. PubMed ID: 18812425
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
Wentao N; Guobao L; Jin Z; Junchang C; Rui W; Zhancheng G; Youning L
J Antibiot (Tokyo); 2018 May; 71(5):506-513. PubMed ID: 29416121
[TBL] [Abstract][Full Text] [Related]
30. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
[TBL] [Abstract][Full Text] [Related]
31. Distribution of β-lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patients in Turkey.
Iraz M; Özad Düzgün A; Sandallı C; Doymaz MZ; Akkoyunlu Y; Saral A; Peleg AY; Özgümüş OB; Beriş FŞ; Karaoğlu H; Çopur Çiçek A
Ann Lab Med; 2015 Nov; 35(6):595-601. PubMed ID: 26354347
[TBL] [Abstract][Full Text] [Related]
32. Activity of polymyxin B combinations against genetically well-characterised Klebsiella pneumoniae producing NDM-1 and OXA-48-like carbapenemases.
Olsson A; Allander L; Shams A; Al-Farsi H; Lagerbäck P; Tängdén T
Int J Antimicrob Agents; 2023 Nov; 62(5):106967. PubMed ID: 37716575
[TBL] [Abstract][Full Text] [Related]
33. Clonal dissemination of multilocus sequence type 11 Klebsiella pneumoniae carbapenemase - producing K. pneumoniae in a Chinese teaching hospital.
Sun K; Chen X; Li C; Yu Z; Zhou Q; Yan Y
APMIS; 2015 Feb; 123(2):123-7. PubMed ID: 25257726
[TBL] [Abstract][Full Text] [Related]
34. A ten-year surveillance study of carbapenemase-producing Klebsiella pneumoniae in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates.
Spyropoulou A; Papadimitriou-Olivgeris M; Bartzavali C; Vamvakopoulou S; Marangos M; Spiliopoulou I; Anastassiou ED; Christofidou M
J Med Microbiol; 2016 Mar; 65(3):240-246. PubMed ID: 26698320
[TBL] [Abstract][Full Text] [Related]
35. Comparison of 3 Etest(®) methods and time-kill assay for determination of antimicrobial synergy against carbapenemase-producing Klebsiella species.
Pankey GA; Ashcraft DS; Dornelles A
Diagn Microbiol Infect Dis; 2013 Nov; 77(3):220-6. PubMed ID: 23993213
[TBL] [Abstract][Full Text] [Related]
36. Klebsiella pneumoniae carbapenemase (KPC) in urinary infection isolates.
Bedenić B; Sardelić S; Bogdanić M; Zarfel G; Beader N; Šuto S; Krilanović M; Vraneš J
Arch Microbiol; 2021 May; 203(4):1825-1831. PubMed ID: 33507339
[TBL] [Abstract][Full Text] [Related]
37. Synergy Testing by E-Test and Microdilution Checkerboard for Fosfomycin Combined with Tigecycline against KPC-Producing Klebsiella pneumoniae.
Huang L; Wang M; Sun L
Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850708
[TBL] [Abstract][Full Text] [Related]
38. In vitro pharmacodynamics of simulated pulmonary exposures of tigecycline alone and in combination against Klebsiella pneumoniae isolates producing a KPC carbapenemase.
Wiskirchen DE; Koomanachai P; Nicasio AM; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2011 Apr; 55(4):1420-7. PubMed ID: 21282442
[TBL] [Abstract][Full Text] [Related]
39. Synergistic effects of Cinnamomum cassia L. essential oil in combination with polymyxin B against carbapenemase-producing Klebsiella pneumoniae and Serratia marcescens.
Vasconcelos NG; Queiroz JHFS; Silva KED; Vasconcelos PCP; Croda J; Simionatto S
PLoS One; 2020; 15(7):e0236505. PubMed ID: 32701970
[TBL] [Abstract][Full Text] [Related]
40. KPC-producing Klebsiella pneumoniae bloodstream isolates from Brazilian hospitals: What (still) remains active?
Antochevis LC; Magagnin CM; Nunes AG; Goulart TM; Martins AS; Cayô R; Gales AC; Barth AL; Zavascki AP
J Glob Antimicrob Resist; 2018 Dec; 15():173-177. PubMed ID: 30071353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]